Harrow Health, Inc. (NASDAQ:HROW)

About the company

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

133

CEO

Mark L. Baum

Exchange

NASDAQ

Website

http://www.harrowinc.com

$51.00M

Total Revenue

133

Employees

$141.18M

Market Capitalization

-5.72

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$34M

Operating Margin (in %)

Total operating margin

$-1M

Net Margin (in %)

Total net margin

$-24M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 396892.01 82729.00 6.38 23.13 20.75
Merck & Co., Inc. MRK 203843.05 48081.00 7.65 20.11 21.10
Pfizer Inc. PFE 201496.53 50660.00 3.05 12.76 31.17
Eli Lilly & Co. LLY 151883.10 23087.00 51.54 26.77 23.97
AbbVie, Inc. ABBV 149112.32 34057.00 -23.87 17.78 24.65
Bristol Myers Squibb Co. BMY 110657.09 31006.00 2.69 94.08 3.08
Repligen Corp. RGEN 6679.47 286.00 6.40 291.04 8.11
Reata Pharmaceuticals, Inc. RETA 4635.12 20.00 21.96 -14.91 -150.30
Nektar Therapeutics NKTR 4340.16 137.00 3.39 -9.45 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3972.28 1.00 36.73 -6.08 None
Allakos, Inc. ALLK 3384.00 None 7.35 -36.18 None
Karuna Therapeutics, Inc. KRTX 2483.26 None 6.48 -61.22 None
OPKO Health, Inc. OPK 2481.67 891.00 1.76 -8.49 -32.92
ADC Therapeutics SA ADCT 2437.02 2.00 28.75 -20.89 None
Turning Point Therapeutics, Inc. TPTX 2274.12 None 6.84 -19.03 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2106.06 None 9.30 -5.05 None
Principia Biopharma, Inc. PRNB 1944.60 30.00 6.92 -27.67 -242.01
IGM Biosciences, Inc. IGMS 1922.00 None 8.47 -35.43 None
Springworks Therapeutics, Inc. SWTX 1652.06 None 5.37 -26.50 None
Y-mAbs Therapeutics, Inc. YMAB 1449.29 None 8.88 -15.73 None
Zymeworks, Inc. ZYME 1289.82 26.00 2.68 -7.60 -629.37
Tricida, Inc. TCDA 1283.80 None 6.60 -6.08 None
Akcea Therapeutics, Inc. AKCA 1248.39 341.00 2.56 -44.38 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1209.45 None 6.26 -10.00 None
Odonate Therapeutics, Inc. ODT 1193.93 None 9.78 -10.61 None
Akero Therapeutics, Inc. AKRO 1081.99 None 10.94 -21.32 None
Arcutis Biotherapeutics, Inc. ARQT 1070.78 None 4.56 -17.12 None
Phibro Animal Health Corp. PAHC 1057.80 818.00 5.34 28.67 4.49
Athenex, Inc. ATNX 938.34 123.00 5.76 -8.72 -87.86
Constellation Pharmaceuticals, Inc. CNST 899.52 None 4.23 -9.69 None
Gossamer Bio, Inc. GOSS 815.26 None 3.31 -4.10 None
Phathom Pharmaceuticals, Inc. PHAT 781.50 None 4.34 -2.87 None
G1 Therapeutics, Inc. GTHX 780.52 1.00 3.38 -5.95 None
Quanterix Corp. QTRX 768.96 60.00 6.78 -17.58 -71.52
Krystal Biotech, Inc. KRYS 716.38 None 4.18 -34.54 None
Arcturus Therapeutics Holdings, Inc. ARCT 702.00 19.00 65.06 -25.23 -151.34
Amneal Pharmaceuticals, Inc. AMRX 680.89 1679.00 4.69 -3.13 -11.85
Applied Therapeutics, Inc. APLT 675.62 14.00 4.36 -13.71 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Oric Pharmaceuticals, Inc. ORIC 669.20 None -7.26 -22.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 602.91 None 5.34 -17.83 None
Keros Therapeutics, Inc. KROS 539.28 8.00 -24.36 -25.39 -285.35
Oyster Point Pharma, Inc. OYST 526.89 None 5.29 -9.16 None
Satsuma Pharmaceuticals, Inc. STSA 483.99 None 4.76 -13.30 None
SIGA Technologies, Inc. SIGA 482.16 19.00 5.39 -24.50 -94.00
Mirum Pharmaceuticals, Inc. MIRM 481.25 None 3.13 -7.10 None
Biospecifics Technologies Corp. BSTC 466.62 40.00 3.79 19.96 61.80
89bio, Inc. ETNB 452.06 None 5.58 -7.00 None
DURECT Corp. DRRX 414.78 28.00 31.86 -17.15 -82.94
Fulcrum Therapeutics, Inc. FULC 407.33 1.00 6.86 -5.90 None
Ocular Therapeutix, Inc. OCUL 401.76 6.00 -49.24 -4.38 None
Relmada Therapeutics, Inc. RLMD 377.82 0.00 5.63 -31.56 -877.66
TCR2 Therapeutics, Inc. TCRR 376.08 None 2.57 -37.31 None
Kala Pharmaceuticals, Inc. KALA 369.72 6.00 4.04 -4.03 None
Imara, Inc. IMRA 368.22 None 3.56 -10.46 None
Crinetics Pharmaceuticals, Inc. CRNX 365.04 1.00 4.61 -6.26 -447.78
Osmotica Pharmaceuticals Plc OSMT 332.37 232.00 2.52 -1.21 -115.44
Ovid Therapeutics, Inc. OVID 330.75 None 7.82 -5.07 None
AMAG Pharmaceuticals, Inc. AMAG 285.26 321.00 1.09 -0.77 -115.05
IDEAYA Biosciences, Inc. IDYA 284.00 None 4.32 -6.51 None
HOOKIPA Pharma, Inc. HOOK 275.34 13.00 2.49 -6.09 -333.02
Aeglea Biotherapeutics, Inc. AGLE 268.29 4.00 8.47 -3.35 -523.27
Urovant Sciences Ltd. UROV 268.20 None -4.76 -1.85 None
Spero Therapeutics, Inc. SPRO 255.74 12.00 3.37 -3.14 -656.72
KalVista Pharmaceuticals, Inc. KALV 223.02 13.00 2.64 -7.55 -229.44
Galera Therapeutics, Inc. GRTX 214.50 None 4.01 -3.26 None
Sutro Biopharma, Inc. STRO 204.70 41.00 3.89 -3.36 -148.06
Veru, Inc. VERU 203.45 39.00 6.96 -20.87 -25.53
Verrica Pharmaceuticals, Inc. VRCA 198.00 None 3.62 -6.49 None
Lannett Co., Inc. LCI 195.32 542.00 0.67 -6.42 -5.77
Kaleido Biosciences, Inc. KLDO 191.10 None 6.78 -2.61 None
LogicBio Therapeutics, Inc. LOGC 168.59 1.00 5.09 -3.96 None
Avenue Therapeutics, Inc. ATXI 158.72 532.00 29.18 -10.90 26.69
Protara Therapeutics, Inc. TARA 156.24 None 2.35 -10.13 None
Tyme Technologies, Inc. TYME 146.05 None 8.47 -6.68 None
Liquidia Technologies, Inc. LQDA 145.20 8.00 11.38 -2.95 -602.17
Lyra Therapeutics, Inc. LYRA 141.84 1.00 -1.20 -8.50 -491.16
PhaseBio Pharmaceuticals, Inc. PHAS 141.23 2.00 2.62 -2.95 None
Harrow Health, Inc. HROW 141.18 51.00 9.05 -5.72 -47.54
scPharmaceuticals, Inc. SCPH 140.41 119.00 3.59 -4.48 -27.05
Gritstone Oncology, Inc. GRTS 139.68 4.00 1.25 -1.34 None
Ayala Pharmaceuticals, Inc. AYLA 137.52 3.00 -3.24 -6.66 -679.19
Cyclerion Therapeutics, Inc. CYCN 134.19 6.00 1.69 -1.29 None
Evelo Biosciences, Inc. EVLO 130.88 None 4.81 -1.49 None
TFF Pharmaceuticals, Inc. TFFP 128.25 None 4.96 -3.31 None
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Immunic, Inc. IMUX 123.30 None 3.63 -56.05 None
Aquestive Therapeutics, Inc. AQST 115.50 49.00 -6.65 -1.64 -139.64
Corvus Pharmaceuticals, Inc. CRVS 115.42 None 1.85 -2.44 None
NeuBase Therapeutics, Inc. NBSE 111.16 None 46.71 -2.49 None
Evolus, Inc. EOLS 101.10 45.00 1.81 -1.00 -217.51
Trevi Therapeutics, Inc. TRVI 96.66 None 2.05 -3.29 None
Eton Pharmaceuticals, Inc. ETON 90.54 1.00 9.86 -4.53 None
Milestone Pharmaceuticals, Inc. MIST 86.50 None 0.85 -1.39 None
Xeris Pharmaceuticals, Inc. XERS 80.92 4.00 4.01 -0.62 None
EyePoint Pharmaceuticals, Inc. EYPT 77.39 26.00 5.46 -1.58 -196.30
Clearside Biomedical, Inc. CLSD 68.88 6.00 8.84 -3.91 -293.61
Navidea Biopharmaceuticals, Inc. NAVB 67.49 1.00 -49.63 -6.11 -65.13
Checkpoint Therapeutics, Inc. CKPT 66.00 2.00 5.69 -2.84 -949.53
Baudax Bio, Inc. BXRX 59.94 None -1.63 -0.85 None
Assertio Therapeutics, Inc. ASRT 59.76 192.00 1.04 -0.37 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.67 1.00 -24.56 -2.04 -851.00
BiomX, Inc. PHGE 58.96 None 1.55 -1.37 None
Genprex, Inc. GNPX 56.24 None 4.77 -4.11 None
Aerpio Pharmaceuticals, Inc. ARPO 54.94 20.00 1.65 -2.91 -51.58
Moleculin Biotech, Inc. MBRX 49.22 None 4.28 -5.35 None
Menlo Therapeutics, Inc. MNLO 46.98 2.00 3.95 -0.50 -483.51
Edesa Biotech, Inc. EDSA 43.38 0.00 6.18 -0.46 -395.23
Eyenovia, Inc. EYEN 42.08 None 4.24 -2.05 None
Annovis Bio, Inc. ANVS 41.58 None 3.81 -33.00 None
Adamis Pharmaceuticals Corp. ADMP 38.28 22.00 1.47 -1.29 -140.33
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
AgeX Therapeutics, Inc. AGE 34.69 2.00 -45.65 -2.85 -658.11
Mannatech, Inc. MTEX 34.40 156.00 1.45 7.75 3.45
Allena Pharmaceuticals, Inc. ALNA 32.66 None 4.30 -0.75 None
Citius Pharmaceuticals, Inc. CTXR 32.40 None 2.40 -1.88 None
Acer Therapeutics, Inc. ACER 31.10 3.00 2.27 -1.19 -274.69
CNS Pharmaceuticals, Inc. CNSP 29.92 None 5.19 -5.50 None
Oncternal Therapeutics, Inc. ONCT 29.77 3.00 3.82 -1.18 -225.89
Hoth Therapeutics, Inc. HOTH 27.40 None 7.61 -3.04 None
Aileron Therapeutics, Inc. ALRN 26.88 None 3.84 -1.01 None
Spring Bank Pharmaceuticals, Inc. SBPH 26.08 0.00 0.99 -1.00 None
Millendo Therapeutics, Inc. MLND 25.50 0.00 0.60 -0.54 None
Daré Bioscience, Inc. DARE 23.94 1.00 10.50 -1.43 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
ProPhase Labs, Inc. PRPH 18.36 9.00 1.66 -6.12 -31.15
Novan, Inc. NOVN 15.66 5.00 -3.60 -0.50 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 14.28 None 1.58 -0.56 None
Adial Pharmaceuticals, Inc. ADIL 13.60 None 3.32 -1.79 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.66 None 0.66 -0.37 None
Brickell Biotech, Inc. BBI 4.15 5.00 1.36 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops

3d ago, source: YAHOO!

a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), is pleased to announce the findings from a randomized contralateral eye study comparing patient outcomes and preferences for a ...

Harrow Health Inc.

9d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Opaleye Management buys more shares in Harrow Health

5d ago, source: Seeking Alpha

(NASDAQ:HROW) +8% discloses the purchase of 136,300 common shares by Opaleye Management for a total of ~$0.69M.

Harrow Health (HROW) in Focus: Stock Moves 6.9% Higher

22d ago, source: YAHOO!

Harrow Health, Inc. HROW was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a ...

Harrow Health Set to Join Russell 2000® Index and Russell 3000® Index

17d ago, source: Benzinga.com

NASHVILLE, Tenn., June 29, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ:HROW) today announced that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000 ...

ImprimisRx's Patented Klarity-C® 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida's 2,000 Optometrists

28d ago, source: Stockhouse

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary ...

Harrow Health Inc.

26d ago, source: MarketWatch

05/26/2020 N/A SC 13G/A Institutional Ownership * 02/14/2020 N/A SC 13G/A Institutional Ownership * 02/14/2019 N/A SC 13G/A Institutional Ownership * 09/07/2018 N/A SC 13G Institutional Ownership ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.